Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma

Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma

10.1186/s13046-019-1352-3

Saved in:

Bibliographic Details
Main Authors:	Pulito, C., Korita, E., Sacconi, A., Valerio, M., Casadei, L., Lo Sardo, F., Mori, F., Ferraiuolo, M., Grasso, G., Maidecchi, A., Lucci, J., Sudol, M., Muti, P., Blandino, G., Strano, S.
Other Authors:	PHYSIOLOGY
Format:	Article
Published:	BioMed Central Ltd. 2021
Subjects:	Cancer metabolism HIPPO tumour suppressor pathway Mesothelioma Phytonutrient YAP
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/212445
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Agave negatively regulates YAP and TAZ transcriptionally and post-translationally in osteosarcoma cell lines
by: Ferraiuolo M., et al.
Published: (2019)

YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer
by: Lo Sardo, Federica, et al.
Published: (2022)

THE INTERPLAY BETWEEN RUNX3 AND TEAD-YAP COMPLEX IN GASTRIC CANCER
by: QIAO YITING
Published: (2015)

Structural basis of YAP recognition by TEAD4 in the Hippo pathway
by: Chen, L., et al.
Published: (2014)

Loss of Yap/taz in cardiac fibroblasts attenuates adverse remodeling and improves cardiac function.
by: Mia, Masum M, et al.
Published: (2021)

INTERPLAY BETWEEN MEVALONATE AND HIPPO PATHWAYS REGULATES DDX20 TRANSCIPTION VIA YAO-TEAD COMPLEX IN TRIPLE NEGATIVE BREAST CANCERS
by: WANG CHAO
Published: (2018)

SPATIOTEMPORAL CONTROL OF YAP LOCALISATION AND FUNCTION IN VITRO AND IN VIVO
by: TOH JIA YING PEARLYN
Published: (2023)

BIOPHYSICAL STUDIES TO ELUCIDATE THE RECOGNITION MECHANISM OF HIPPO PATHWAY EFFECTORS YAP AND TAZ BY LATS1
by: APOORVA VERMA
Published: (2018)

IDENTIFICATION AND CHARACTERIZATION OF REGULATORY NON-CODING RNAS IN THE HIPPO-YAP/TAZ SIGNALING PATHWAY
by: ZHU BOWEN
Published: (2020)

An update on targeting Hippo-YAP signaling in liver cancer
by: Liu, A.M., et al.
Published: (2014)

Emerging roles of TEAD transcription factors and its coactivators in cancers
by: Pobbati, A.V., et al.
Published: (2014)

MiR-582-5p is a tumor suppressor microRNA targeting the Hippo-YAP/TAZ signaling pathway in non-small cell lung cancer
by: Zhu, Bowen, et al.
Published: (2022)

Common and unique transcription signatures of YAP and TAZ in gastric cancer cells
by: Lee, Y., et al.
Published: (2021)

Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex
by: Kristal Kaan, H.Y, et al.
Published: (2020)

Targeting YAP/TAZ-TEAD protein-protein interactions using fragment-based and computational modeling approaches
by: Kaan H.Y.K., et al.
Published: (2020)

The multiple interactions of RUNX with the hippo–YAP pathway
by: Chuang, Linda Shyue Huey, et al.
Published: (2022)

Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
by: Collins, DC, et al.
Published: (2021)

MiR-520b promotes breast cancer stemness through hippo/YAP signaling pathway
by: Zhang, H., et al.
Published: (2022)

WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ
by: Chan, S.W., et al.
Published: (2014)

Regulators of mammalian Hippo pathway in cancer
by: Liu, A.M., et al.
Published: (2014)

AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
by: Xu, M.Z., et al.
Published: (2014)

GENOME-WIDE CRISPR SCREEN IDENTIFIES AN NF2-ADHERENS JUNCTION MECHANISTIC DEPENDENCY FOR CARDIAC LINEAGE
by: LEE CHANG JIE MICK
Published: (2022)

YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction
by: Mia, Masum M, et al.
Published: (2021)

The doctor in claims for work injuries and ill health - Legal pitfalls
by: Lee, S.-M., et al.
Published: (2011)

Targeting YAP/TAZ-TEAD protein-protein interactions using fragment-based and computational modeling approaches
by: Kaan, Hung Yi Kristal, et al.
Published: (2018)

Zika virus alters DNA methylation status of genes involved in Hippo signaling pathway in human neural progenitor cells.
by: Kandilya, Deepika, et al.
Published: (2019)

A philosophical reading of the conversion of St. Augustine
by: Marollano, Carmelo P.
Published: (2023)

Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents
by: Pasdar E.A., et al.
Published: (2019)

Emerging roles of the Hippo signaling pathway in modulating immune response and inflammation-driven tissue repair and remodeling
by: Mia, Masum M, et al.
Published: (2022)

Structural and functional similarity between the Vgll1-TEAD and the YAP-TEAD complexes
by: Pobbati, A.V., et al.
Published: (2014)

WBP2 PROMOTES GASTRIC CANCER CELL MIGRATION BY INHIBITING THE HIPPO SIGNALLING PATHWAY
by: MELISSA HUM WEN CHING
Published: (2018)

NAVEL-GAZING SINGAPORE IN VERSE
by: TEO BEE LAN
Published: (2020)

BNIP-2 ACTIVATION OF FORCE DRIVES YAP CYTOSOLIC RETENTION FOR CARDIOMYOCYTE DIFFERENTIATION
by: WONG CHEN PEI DARREN
Published: (2020)

POPX2 is a novel LATS phosphatase that regulates the Hippo pathway
by: Muhammad Bakhait Rahmat, et al.
Published: (2019)

The Hippo Signaling Pathway in Cardiac Development and Diseases.
by: MIA MD MASUM, et al.
Published: (2020)

SKP1 promotes YAP-mediated colorectal cancer stemness via suppressing RASSF1
by: Tian, C., et al.
Published: (2021)

Malignant mesothelioma in Singapore
by: Ho, S.F., et al.
Published: (2014)

Linking extracellular matrix agrin to the hippo pathway in liver cancer and beyond
by: Chakraborty, S, et al.
Published: (2020)

THE ROLE OF THE HIPPO PATHWAY IN ONCOGENIC TRANSFORMATION
by: NGUYEN THANH HUNG
Published: (2014)

CHARACTERIZING THE ROLE OF FREE FATTY ACID RECEPTORS (FFARs) IN BREAST CANCER CELLS
by: MADHUMATHI THIRUNAVUKKARASAN
Published: (2017)